Review Article

PI-RADS v2.1: What has changed and how to report

Robin Scott, Shalendra K. Misser, Dania Cioni, Emanuele Neri
South African Journal of Radiology | Vol 25, No 1 | a2062 | DOI: https://doi.org/10.4102/sajr.v25i1.2062 | © 2021 Robin Scott, Shalendra K. Misser, Dania Cioni, Emanuele Neri | This work is licensed under CC Attribution 4.0
Submitted: 08 December 2020 | Published: 01 June 2021

About the author(s)

Robin Scott, Department of Radiology, Lake, Smit and Partners Inc., Durban, South Africa
Shalendra K. Misser, Department of Radiology, Lake, Smit and Partners Inc., Durban, South Africa; and, Department of Radiology, Faculty of Health Sciences Medicine, College of Health Sciences, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durba, South Africa
Dania Cioni, Department of Translational Research, Academic Radiology, University of Pisa, Pisa, Italy
Emanuele Neri, Department of Translational Research, Academic Radiology, University of Pisa, Pisa, Italy

Abstract

Multiparametric magnetic resonance imaging (MRI) of the prostate has become a vital imaging tool in daily radiological practice for the stratification of the risk of prostate cancer. There has been a recent update to the Prostate Imaging-Reporting and Data System (PI-RADS). The updated changes in PI-RADS, which is version 2.1, have been described with information pertaining to the recommended imaging protocols, the techniques on how to perform prostate MRI and a simplified approach to interpreting and reporting MRI of the prostate. Explanatory tables, schematic diagrams and key representative images have been used to provide the reader with a useful approach to interpreting and then stratifying lesions in the four anatomical zones of the prostate gland. The intention of this article is to address challenges of interpretation and reporting of prostate lesions in daily practice.

Keywords

prostate carcinoma; PI-RADS; magnetic resonance imaging; technical parameters for mpMRI of prostate; assessment categories to stratify risk; structured reporting

Metrics

Total abstract views: 6897
Total article views: 8015

 

Crossref Citations

1. Development and validation of a nomogram for predicting prostate cancer based on combining contrast-enhanced transrectal ultrasound and biparametric MRI imaging
Wanxian Nong, Qun Huang, Yong Gao
Frontiers in Oncology  vol: 13  year: 2023  
doi: 10.3389/fonc.2023.1275773

2. Interpreting Prostate MRI Reports in the Era of Increasing Prostate MRI Utilization: A Urologist’s Perspective
Kevin Miszewski, Katarzyna Skrobisz, Laura Miszewska, Marcin Matuszewski
Diagnostics  vol: 14  issue: 10  first page: 1060  year: 2024  
doi: 10.3390/diagnostics14101060

3. Utility of quantitative measurement of T2 using restriction spectrum imaging for detection of clinically significant prostate cancer
Mariluz Rojo Domingo, Christopher C. Conlin, Roshan Karunamuni, Courtney Ollison, Madison T. Baxter, Karoline Kallis, Deondre D. Do, Yuze Song, Joshua Kuperman, Ahmed S. Shabaik, Michael E. Hahn, Paul M. Murphy, Rebecca Rakow-Penner, Anders M. Dale, Tyler M. Seibert
Scientific Reports  vol: 14  issue: 1  year: 2024  
doi: 10.1038/s41598-024-82742-8

4. Enhancing bone metastasis prediction in prostate cancer using quantitative mpMRI features, ISUP grade and PSA density: a machine learning approach
Hasan Gündoğdu, Kemal Panç, Sümeyye Sekmen, Hüseyin Er, Enes Gürün
Abdominal Radiology  vol: 50  issue: 5  first page: 2221  year: 2024  
doi: 10.1007/s00261-024-04667-0

5. Effective reduction of unnecessary biopsies through a deep-learning-assisted aggressive prostate cancer detector
Nuno M. Rodrigues, José Guilherme de Almeida, Ana Sofia Castro Verde, Ana Mascarenhas Gaivão, Carlos Bireiro, Inês Santiago, Joana Ip, Sara Belião, Celso Matos, Leonardo Vanneschi, Manolis Tsiknakis, Kostas Marias, Daniele Regge, Sara Silva, Manolis Tsiknakis, Kostas Marias, Stelios Sfakianakis, Varvara Kalokyri, Eleftherios Trivizakis, Grigorios Kalliatakis, Avtantil Dimitriadis, Dimitris Fotiadis, Nikolaos Tachos, Eugenia Mylona, Dimitris Zaridis, Charalampos Kalantzopoulos, Nikolaos Papanikolaou, José Guilherme de Almeida, Ana Castro Verde, Ana Carolina Rodrigues, Nuno Rodrigues, Miguel Chambel, Henkjan Huisman, Maarten de Rooij, Anindo Saha, Jasper J. Twilt, Jurgen Futterer, Luis Martí-Bonmatí, Leonor Cerdá-Alberich, Gloria Ribas, Silvia Navarro, Manuel Marfil, Emanuele Neri, Giacomo Aringhieri, Lorenzo Tumminello, Vincenzo Mendola, Deniz Akata, Mustafa Özmen, Ali Devrim Karaosmanoglu, Firat Atak, Musturay Karcaaltincaba, Joan C. Vilanova, Jurgita Usinskiene, Ruta Briediene, Audrius Untanas, Kristina Slidevska, Katsaros Vasilis, Georgiou Georgios, Dow-Mu Koh, Robby Emsley, Sharon Vit, Ana Ribeiro, Simon Doran, Tiaan Jacobs, Gracián García-Martí, Daniele Regge, Valentina Giannini, Simone Mazzetti, Giovanni Cappello, Giovanni Maimone, Valentina Napolitano, Sara Colantonio, Maria Antonietta Pascali, Eva Pachetti, Giulio del Corso, Danila Germanese, Andrea Berti, Gianluca Carloni, Jayashree Kalpathy-Cramer, Christopher Bridge, Joao Correia, Walter Hernandez, Zoi Giavri, Christos Pollalis, Dimitrios Agraniotis, Ana Jiménez Pastor, Jose Munuera Mora, Clara Saillant, Theresa Henne, Rodessa Marquez, Nickolas Papanikolaou
Scientific Reports  vol: 15  issue: 1  year: 2025  
doi: 10.1038/s41598-025-99795-y

6. Analysis of gray zone PSA and PSAD correlated with PIRADS v2.1 in the MRI-US fusion prostate biopsy era: a retrospective bi-centre study
Michelangelo S. Cobangbang, Bryian P. Paner, Jerome Kyle R. San Jose, Miguel Antonio D. Isada, Paul Anthony L. Sunga
International Urology and Nephrology  vol: 57  issue: 12  first page: 3933  year: 2025  
doi: 10.1007/s11255-025-04551-w

7. 3.0 T prostate MRI: Visual assessment of 2D and 3D T2-weighted imaging sequences using PI-QUAL score
Nina Brillat-Savarin, Carine Wu, Laurène Aupin, Camille Thoumin, Dimitri Hamzaoui, Raphaële Renard-Penna
European Journal of Radiology  vol: 166  first page: 110974  year: 2023  
doi: 10.1016/j.ejrad.2023.110974

8. Diagnostic performance of conventional MRI using T1W and T2W for primary lymph node staging in intermediate- and high-risk prostate cancer patients prior to pelvic lymph node dissection
Georgios Daouacher, Jessica Carlsson, Nikolaos Voulgarakis, Sofia Papageorgiou, Pär Dahlman, Pernilla Sundqvist, Mauritz Waldén
Abdominal Radiology  year: 2025  
doi: 10.1007/s00261-025-05073-w

9. Integration of magnetic resonance imaging and deep learning for prostate cancer detection: a systematic review
Deepak Kumar
American Journal of Clinical and Experimental Urology  vol: 13  issue: 2  first page: 69  year: 2025  
doi: 10.62347/CSIJ8326

10. Biparametric Prostate MRI: A Practical Approach to Implementation and Comparative Analysis
Olivia Muhn, Darya Kurowecki, Michael N. Patlas, Abdullah Alabousi
Canadian Association of Radiologists Journal  year: 2025  
doi: 10.1177/08465371251342706

11. Combination of prostate cancer antigen 3 (PCA3), sarcosine, glypican-1 (GPC1), urokinase plasminogen activator receptor (uPAR), and thymidine kinase 1 (TK1), and T2WI and DWI radiomics model for distinguishing benign prostatic hyperplasia, prostate cancer, and prostatitis
Fan Yang, Wei Guo, Siqin Sun, Yanan Huang
Journal of Medical Biochemistry  vol: 44  issue: 6  first page: 1376  year: 2025  
doi: 10.5937/jomb0-57639

12. Diagnostic Accuracy of Combination of Multiparametric MRI PI-RADS Score v2.1 and Prostate-Specific Antigen Density for Prostate Cancer Detection
Ashrita Shetty, Jahnavi Gadupati, Bhagyalakshmi Bommineni, Sowmya Chikatla, Umesh Krishnamurthy, Ramesh D
Cureus  year: 2025  
doi: 10.7759/cureus.80238

13. Comparing and Combining Artificial Intelligence and Spectral/Statistical Approaches for Elevating Prostate Cancer Assessment in a Biparametric MRI: A Pilot Study
Rulon Mayer, Yuan Yuan, Jayaram Udupa, Baris Turkbey, Peter Choyke, Dong Han, Haibo Lin, Charles B. Simone
Diagnostics  vol: 15  issue: 5  first page: 625  year: 2025  
doi: 10.3390/diagnostics15050625

14. Mapping of prostate cancer microvascular patterns using super-resolution ultrasound imaging
Mairead B. Butler, Georgios Papageorgiou, Evangelos D. Kanoulas, Vasiliki Voulgaridou, Hessel Wijkstra, Massimo Mischi, Christophe K. Mannaerts, Steven McDougall, William Colin Duncan, Weiping Lu, Vassilis Sboros
European Radiology Experimental  vol: 9  issue: 1  year: 2025  
doi: 10.1186/s41747-025-00561-6

15. Robot-Assisted Radical Prostatectomy in PIRADS 5 Lesions Without Prior Biopsy: Is Biopsy Really Necessary in This Cohort?
Shirin Razdan, Sneha Parekh, Emelia K. Watts, Jainer Munoz, Jayesh Parmar, Nile M. Khanfar, Christopher Woodhouse, Sanjay Razdan
Journal of Endourology  vol: 38  issue: 10  first page: 1062  year: 2024  
doi: 10.1089/end.2024.0124

16. Enhanced detection of clinically significant prostate cancer in targeted and non-targeted regions using BiopSee® MRI/ultrasound fusion biopsy
Ken Nakahara
American Journal of Clinical and Experimental Urology  vol: 13  issue: 4  first page: 265  year: 2025  
doi: 10.62347/QODA6396